Eric Warren sold $2.7M of Mineralys Therapeutics (MLYS)

Executed Jun 26, disclosed Jun 30, 4 days later.

Value, as filed

$2.7M

104,124 sh × $25.90

Executed

Jun 26

the trade date, as filed

Disclosed

Jun 30

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EW Eric Warren Chief Commercial Officer profile →

Eric Warren (Chief Commercial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $2.7M of MLYS (104,124 sh × $25.90, as filed), executed Jun 26.

The name

MLYS Mineralys Therapeutics, Inc. MLYS · Healthcare · 50 filings in 24 months ticker →

Healthcare · Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eric Warren in MLYS

MLYSSALE Mineralys Therapeutics, Inc. $193K
7,437 sh × $25.98
Exec Aug 21
Filed Aug 25 · 5:16 PM ET MLYSSALE Mineralys Therapeutics, Inc. $200K
7,438 sh × $26.87
Exec Jul 21
Filed Jul 23 · 6:39 PM ET